Chicken Pox Info
Sunday, January 29, 2023
  • Home
  • Chickenpox
  • Monkeypox
  • Cowpox
  • Goatpox
  • Horsepox
  • Sheeppox
  • Squirrelpox
No Result
View All Result
  • Home
  • Chickenpox
  • Monkeypox
  • Cowpox
  • Goatpox
  • Horsepox
  • Sheeppox
  • Squirrelpox
No Result
View All Result
Chicken Pox Info
No Result
View All Result
Home Monkeypox

U.S. Will Lift Monkeypox Emergency Declaration

Chickenpox Info by Chickenpox Info
December 8, 2022
in Monkeypox
0
U.S. Will Lift Monkeypox Emergency Declaration
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


On December 2, U.S. Department of Health and Human Services Secretary Xavier Becerra announced that the federal government intends to end the public health emergency declaration for monkeypox, now renamed mpox. The Biden administration does not expect to renew the declaration when it expires at the end of January.

The current global mpox outbreak was first identified in the United Kingdom in early May. As of December 7, the Centers for Disease Control and Prevention (CDC) has identified 29,711 cases of mpox in the United States and more than 82,000 cases worldwide, mostly in countries that have not historically reported the disease. A large majority of cases have been among gay, bisexual and other men who have sex with men, and sexual contact is the most commonly reported transmission route.

RELATED POSTS

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.

As previously reported, the Department of Health and Human Services (HHS) declared the then-growing mpox outbreak a public health emergency on August 4.  This followed emergency declarations by the World Health Organization; states including California, Illinois and New York; and some cities with high case numbers.

Mpox incidence has since declined by more than 90% from its peak in July and August, according to White House national monkeypox response deputy coordinator Demetre Daskalakis, MD, MPH. Experts attribute the decrease to a combination of factors, including immunity in the initially infected group, rapid vaccine uptake and behavior changes, such as having fewer sex partners.

Updated #mpox epidemic curve from @CDCgov showing steady progress. Vaccinations with 1st and 2nd doses continue to decline. We need to keep emphasizing the importance of vaccine in maintaining protection to durably end this outbreak. Find vaccine at https://t.co/SLGExN0pL8 pic.twitter.com/gj7BfbCsXw

— DrDemetre (@dr_demetre) December 7, 2022

While the dramatic decline in mpox has been a rare bit of good news in the response to recent disease outbreaks, some public health experts and advocates fear the virus will not be eliminated, but rather could continue to circulate at low levels, especially among disadvantaged communities. By late summer, more than half of people with mpox were Black and Latino men who have sex with men, and the outbreak increasingly mirrors the same long-standing disparities evident in the U.S. HIV epidemic.

The emergency declaration enabled the federal government to devote more resources to the crisis, encouraged states to share more data with the CDC and spurred the implementation of a new dose-sparing vaccine strategy that allows a single dose to be split between five people using an intradermal administration method.

But advocates criticized the administration for its delays in procuring and distributing mpox vaccines and the antiviral medical TPOXX (tecovirimat). They also noted that increased funds did not materialize because Congress has failed to authorize money specifically for mpox and continued COVID-19 funding. This has left state and local public health departments and sexual health and HIV services struggling to add mpox to their existing workload without additional resources. To address this shortfall, the CDC and the Health Resources and Services Administration gave grantees the flexibility to repurpose funds earmarked for HIV and sexually transmitted infection services to support the mpox response.

Now, with cases at a low level nationwide, the federal government has decided to let the emergency declaration expire.

“From the outset of the mpox outbreak, the administration pulled every lever to stop the spread of this virus,” Becerra said in a statement. “Given the low number of cases today, HHS does not expect that it needs to renew the emergency declaration when it ends on January 31, 2023. But we won’t take our foot off the gas—we will continue to monitor the case trends closely and encourage all at-risk individuals to get a free vaccine. As we move into the next phase of this effort, the Biden-Harris Administration continues working closely with jurisdictions and partners to monitor trends, especially in communities that have been disproportionately affected.”

Click here for more news about mpox.




ShareTweetPin
Chickenpox Info

Chickenpox Info

Related Posts

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

by Chickenpox Info
January 27, 2023
0

Pharmacists should consider 2 critical safety issues when treating or vaccinating patients for monkeypox.First, it is vital to understand that...

Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.

Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.

by Chickenpox Info
January 27, 2023
0

Future Market Insights Global and Consulting Pvt. Ltd.Asia Pacific Monkeypox Treatment Market is projected to witness the fastest growth of...

Global Monkeypox Treatment Market to reach US$ 249 million

Global Monkeypox Treatment Market to reach US$ 249 million

by Chickenpox Info
January 27, 2023
0

DUBAI, United Arab Emirates, Jan. 26, 2023 (GLOBE NEWSWIRE) -- A recent Future Market Insights report on the monkeypox treatment...

Florida Health Orange County

DOH-Orange MPOX / Monkeypox Vaccination Update #12

by Chickenpox Info
January 26, 2023
0

Contact: Kent Donahue Kent.Donahue@flhealth.gov407-858-1418  ORLANDO, FL – The following update is provided to keep the community informed on the Florida Department...

Study: Clinical Testing of Pediatric Mpox Specimens: Unique Features and Challenges in a Low Prevalence Population. Image Credit: Dotted Yeti / Shutterstock

An evaluation of pediatric Mpox specimens

by Chickenpox Info
January 25, 2023
0

In a recent study posted to the medRxiv* preprint server, researchers in the United States performed the clinical evaluation of...

Next Post
Monkeypox Renamed to "Mpox" by WHO, Here's Why

Monkeypox Renamed to "Mpox" by WHO, Here's Why

CDC: More Than 29K Monkeypox Cases Reported in US

Health Ministry Detects New Monkeypox Infection

RECOMMENDED

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

January 27, 2023
Global Monkeypox Treatment Market to reach US$ 249 million

Global Monkeypox Treatment Market to reach US$ 249 million

January 27, 2023

MOST VIEWED

  • Can you catch chickenpox twice? How contagious is virus and symptoms explained

    How long does chickenpox last? When do symptoms go away, how long is it contagious – and is there treatment

    0 shares
    Share 0 Tweet 0
  • What happened to monkeypox? Answers to your most pressing questions.

    0 shares
    Share 0 Tweet 0
  • TikTok craze of using calamine lotion as makeup causing chickenpox treatment shortages, pharmacy warns

    0 shares
    Share 0 Tweet 0
  • Research finds link between chickenpox and Alzheimer’s

    0 shares
    Share 0 Tweet 0
  • Can monkeypox spread through contaminated food?

    0 shares
    Share 0 Tweet 0

Chicken Pox Info

Welcome to Chicken Pox Info, where you will get all the latest news about all the different pox diseases, to stay up to date, and to protect yourself.

CATEGORY

  • Chickenpox
  • Cowpox
  • Goatpox
  • Horsepox
  • Monkeypox
  • Sheeppox
  • Squirrelpox

Site Links

  • Home
  • About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions

Latest News

  • Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox
  • Global Monkeypox Treatment Market to reach US$ 249 million
  • Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.

Copyright © 2022 Chickenpoxinfo.com | All Rights Reserved.

No Result
View All Result
  • Home
  • Chickenpox
  • Monkeypox
  • Cowpox
  • Goatpox
  • Horsepox
  • Sheeppox
  • Squirrelpox

Copyright © 2022 Chickenpoxinfo.com | All Rights Reserved.

What Are Cookies
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT